Tapan Maniar

Tapan Maniar is a seasoned professional in biotechnology and pharmaceuticals, currently serving as the Chief Business Officer and Co-Founder at Verdiva Bio since October 2024. Prior to this role, Tapan held similar positions at Aiolos Bio, and contributed as a Board Observer for Emalex Biosciences and Rivus Pharmaceuticals. Tapan has significant experience from Bain Capital as a Principal, and led business development efforts at Genentech, focusing on technology platforms and partnerships across therapeutic areas. Earlier career milestones include roles at McKinsey & Company as an Engagement Manager and Associate, as well as a Postdoctoral Associate at Rockefeller University. Tapan earned a Ph.D. in Neuroscience from The Rockefeller University and a B.A. in Biology from Bard College.